AGTR1 as a therapeutic target in ER-positive and  ERBB2-negative breast cancer cases.
Ateeq
Bushra
B
Tomlins
Scott A
SA
Chinnaiyan
Arul M
AM
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology; D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D019808:Losartan / Q000494:pharmacology; D051379:Mice; D008819:Mice, Nude; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism*; D015398:Signal Transduction; D014183:Transplantation, Heterologous
D047228:Angiotensin II Type 1 Receptor Blockers; D019808:Losartan; D044140:Receptor, Angiotensin, Type 1; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; C544065:AGTR1 protein, human; C508053:ERBB2 protein, human